Literature DB >> 19504616

Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.

Marianna Roselli1, Alberto Finamore, Silvia Nuccitelli, Paola Carnevali, Patrizia Brigidi, Beatrice Vitali, Fabio Nobili, Rita Rami, Ivana Garaguso, Elena Mengheri.   

Abstract

BACKGROUND: Probiotics may protect against inflammatory bowel disease through regulation of lamina propria lymphocytes (LPLs) function. Data are lacking on possible involvement of intraepithelial lymphocytes (IELs). The aim of this study was to investigate whether different probiotic mixtures prevented gut inflammatory disease and the role of both IELs and LPLs.
METHODS: BALB/c mice received 2 probiotic mixtures orally for 3 weeks, as Mix1 (Lactobacillus acidophilus and Bifidobacterium longum), or Mix2 (Lactobacillus plantarum, Streptococcus thermophilus, and Bifidobacterium animalis subsp. lactis). Colitis was induced by intrarectal administration of trinitrobenzene sulfonic acid (TNBS). Probiotics in stools were analyzed by real-time polymerase chain reaction (PCR). Colon subpopulations of IELs and LPLs were assayed by flow cytometry. Serum cytokines were measured by cytometric bead array (CBA).
RESULTS: All probiotics colonized the intestine. The 2 mixtures prevented the TNBS-induced intestinal damage, and Mix1 was the most effective. The Mix1 protection was associated with a reduction in CD4(+) cells of IELs and LPLs, an increase in gammadeltaT cells of IELs, and a decrease in gammadeltaT cells of LPLs. An expansion of T regulatory (Treg) cells of IELs was induced by Mix1 and Mix2. Both probiotic mixtures inhibited tumor necrosis factor (TNF)-alpha and monocyte chemotactic protein (MCP)-1 production and upregulated interleukin (IL)-10. In addition, Mix1 prevented the TNBS-induced increase of IL-12 and interferon (IFN)-gamma.
CONCLUSIONS: The 2 probiotic mixtures were able to prevent the TNBS-induced colitis; the L. acidophilus and B. longum mixture was the most effective. Other than an involvement of LPLs, our results report a novel importance of the IELs population in probiotic protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504616     DOI: 10.1002/ibd.20961

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  46 in total

Review 1.  Influence of dietary components on regulatory T cells.

Authors:  Shohreh Issazadeh-Navikas; Roman Teimer; Robert Bockermann
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 2.  Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa.

Authors:  Peter A Bron; Peter van Baarlen; Michiel Kleerebezem
Journal:  Nat Rev Microbiol       Date:  2011-11-21       Impact factor: 60.633

3.  Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

Authors:  Julia Preising; David Philippe; Marita Gleinser; Hua Wei; Stephanie Blum; Bernhard J Eikmanns; Jan-Hendrik Niess; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

4.  Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.

Authors:  Li Zuo; Kai-Tao Yuan; Li Yu; Qing-Hong Meng; Peter Chee-Keung Chung; Ding-Hua Yang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 5.  Probiotics-host communication: Modulation of signaling pathways in the intestine.

Authors:  Carissa M Thomas; James Versalovic
Journal:  Gut Microbes       Date:  2010 May-Jun

6.  Imiquimod-induced CCR9 Ameliorates murine TNBS Colitis.

Authors:  Ryoma Suzuki; Kyoko Katakura; Tatsuo Fujiwara; Naohiko Gunji; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2016-11-10

7.  NOD1 in the modulation of host-microbe interactions and inflammatory bone resorption in the periodontal disease model.

Authors:  João Antônio Chaves de Souza; Sabrina Cruz Tfaile Frasnelli; Fabiana de Almeida Curylofo-Zotti; Mário Julio Ávila-Campos; Luis Carlos Spolidório; Dario Simões Zamboni; Dana T Graves; Carlos Rossa
Journal:  Immunology       Date:  2016-09-06       Impact factor: 7.397

Review 8.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 9.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

10.  Impact of a synbiotic food on the gut microbial ecology and metabolic profiles.

Authors:  Beatrice Vitali; Maurice Ndagijimana; Federica Cruciani; Paola Carnevali; Marco Candela; Maria Elisabetta Guerzoni; Patrizia Brigidi
Journal:  BMC Microbiol       Date:  2010-01-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.